Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sarepta Therapeutics Inc.

    NASDAQ: SRPT · Real-Time Price · USD
    20.99
    -15.19 (-41.98%)
    At close: Jun 16, 2025, 3:59 PM
    21.95
    4.57%
    After-hours: Jun 16, 2025, 07:59 PM EDT

    Sarepta Therapeutics Statistics

    Share Statistics

    Sarepta Therapeutics has 98.28M shares outstanding. The number of shares has increased by 2.65% in one year.

    Shares Outstanding

    n/a
    		 98.28M

    Shares Change (YoY)

    n/a
    		 2.65%

    Shares Change (QoQ)

    n/a
    		 1.58%

    Owned by Institutions (%)

    n/a
    		 93.56%

    Shares Floating

    n/a
    		 93.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 17,712

    FTD / Avg. Volume

    n/a
    		 0.45%

    Short Selling Information

    The latest short interest is 9.26M, so 9.43% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.26M

    Short % of Shares Out

    n/a
    		 9.43%

    Short % of Float

    n/a
    		 11.04%

    Short Ratio (days to cover)

    n/a
    		 2.35

    Valuation Ratios

    The PE ratio is 49.14 and the forward PE ratio is 5.26. Sarepta Therapeutics's PEG ratio is -0.35.

    PE Ratio

    n/a
    		 49.14

    Forward PE

    n/a
    		 5.26

    PS Ratio

    n/a
    		 6.08

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 7.57

    P/FCF Ratio

    n/a
    		 -33.73

    PEG Ratio

    n/a
    		 -0.35
    Financial Ratio History

    Enterprise Valuation

    Sarepta Therapeutics has an Enterprise Value (EV) of 11.8B.

    EV / Sales

    n/a
    		 6.2

    EV / EBITDA

    n/a
    		 35.43

    EV / EBIT

    n/a
    		 -57.34

    EV / FCF

    n/a
    		 -34.43

    Financial Position

    The company has a current ratio of 4.2, with a Debt / Equity ratio of 0.88.

    Current Ratio

    n/a
    		 4.2

    Quick Ratio

    n/a
    		 3.18

    Debt / Equity

    n/a
    		 0.88

    Debt / EBITDA

    n/a
    		 4.03

    Debt / FCF

    n/a
    		 -3.92

    Interest Coverage

    n/a
    		 11.86

    Financial Efficiency

    Return on Equity is 15.4% and Return on Invested Capital is 6.06%.

    Return on Equity

    n/a
    		 15.4%

    Return on Assets

    n/a
    		 5.94%

    Return on Invested Capital

    n/a
    		 6.06%

    Revenue Per Employee

    n/a
    		 $1,386,282.07

    Profits Per Employee

    n/a
    		 $171,457

    Employee Count

    n/a
    		 1,372

    Asset Turnover

    n/a
    		 0.48

    Inventory Turnover

    n/a
    		 0.43

    Taxes

    Income Tax

    n/a
    		 25.54M

    Effective Tax Rate

    n/a
    		 9.79%

    Stock Price Statistics

    The stock price has increased by -82.03% in the last 52 weeks. The beta is 0.6, so Sarepta Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.6

    52-Week Price Change

    n/a
    		 -82.03%

    50-Day Moving Average

    n/a
    		 45.86

    200-Day Moving Average

    n/a
    		 97.96

    Relative Strength Index (RSI)

    n/a
    		 19.99

    Average Volume (20 Days)

    n/a
    		 3,899,928

    Income Statement

    In the last 12 months, Sarepta Therapeutics had revenue of 1.9B and earned 235.24M in profits. Earnings per share was 2.34.

    Revenue

    n/a
    		 1.9B

    Gross Profit

    n/a
    		 1.58B

    Operating Income

    n/a
    		 218.08M

    Net Income

    n/a
    		 235.24M

    EBITDA

    n/a
    		 333.06M

    EBIT

    n/a
    		 279.17M

    Earnings Per Share (EPS)

    n/a
    		 2.34
    Full Income Statement

    Balance Sheet

    The company has 1.1B in cash and 1.34B in debt, giving a net cash position of -240.06M.

    Cash & Cash Equivalents

    n/a
    		 1.1B

    Total Debt

    n/a
    		 1.34B

    Net Cash

    n/a
    		 -240.06M

    Retained Earnings

    n/a
    		 -4.21B

    Total Assets

    n/a
    		 3.47B

    Working Capital

    n/a
    		 1.83B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -205.79M and capital expenditures -136.96M, giving a free cash flow of -342.74M.

    Operating Cash Flow

    n/a
    		 -205.79M

    Capital Expenditures

    n/a
    		 -136.96M

    Free Cash Flow

    n/a
    		 -342.74M

    FCF Per Share

    n/a
    		 -3.6
    Full Cash Flow Statement

    Margins

    Gross margin is 83.22%, with operating and profit margins of 11.47% and 12.37%.

    Gross Margin

    n/a
    		 83.22%

    Operating Margin

    n/a
    		 11.47%

    Pretax Margin

    n/a
    		 13.71%

    Profit Margin

    n/a
    		 12.37%

    EBITDA Margin

    n/a
    		 17.51%

    EBIT Margin

    n/a
    		 11.47%

    FCF Margin

    n/a
    		 -18.02%

    Dividends & Yields

    SRPT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 2.03%

    FCF Yield

    n/a
    		 -2.96%
    Dividend Details

    Analyst Forecast

    The average price target for SRPT is $98.5, which is 369.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $98.5

    Price Target Difference

    n/a
    		 369.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 22
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 29.91

    Graham Upside

    n/a
    		 42.5%

    Stock Splits

    The last stock split was on Jul 12, 2012. It was a backward split with a ratio of 1:6.

    Last Split Date

    n/a
    		 Jul 12, 2012

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:6

    Scores

    Altman Z-Score

    n/a
    		 0.22

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist